Cargando…

CREB3L1 overexpression as a potential diagnostic marker of Philadelphia chromosome–negative myeloproliferative neoplasms

Discrimination of Philadelphia‐negative myeloproliferative neoplasms (Ph‐MPNs) from reactive hypercytosis and myelofibrosis requires a constellation of testing including driver mutation analysis and bone marrow biopsies. We searched for a biomarker that can more easily distinguish Ph‐MPNs from react...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morishita, Soji, Yasuda, Hajime, Yamawaki, Saya, Kawaji, Hideya, Itoh, Masayoshi, Edahiro, Yoko, Imai, Misa, Kogo, Yasushi, Tsuneda, Satoshi, Ohsaka, Akimichi, Hayashizaki, Yoshihide, Ito, Masafumi, Araki, Marito, Komatsu, Norio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7893984/ https://www.ncbi.nlm.nih.gov/pubmed/33280191 http://dx.doi.org/10.1111/cas.14763

Ejemplares similares

Melting Curve Analysis after T Allele Enrichment (MelcaTle) as a Highly Sensitive and Reliable Method for Detecting the JAK2V617F Mutation
por: Morishita, Soji, et al.
Publicado: (2015)

Detection of MPLW515L/K Mutations and Determination of Allele Frequencies with a Single-Tube PCR Assay
por: Takei, Hiraku, et al.
Publicado: (2014)

Identification of AIM2 as a downstream target of JAK2V617F
por: Liew, Ei Leen, et al.
Publicado: (2016)

Inhibition of the NAD-Dependent Protein Deacetylase SIRT2 Induces Granulocytic Differentiation in Human Leukemia Cells
por: Sunami, Yoshitaka, et al.
Publicado: (2013)

Correction: Inhibition of the NAD-Dependent Protein Deacetylase SIRT2 Induces Granulocytic Differentiation in Human Leukemia Cells
por: Sunami, Yoshitaka, et al.
Publicado: (2013)

Mechanism underlying the development of myeloproliferative neoplasms through mutant calreticulin
por: Edahiro, Yoko, et al.
Publicado: (2020)

Causes of Thrombocytosis: A Single-center Retrospective Study of 1,202 Patients
por: Edahiro, Yoko, et al.
Publicado: (2022)

Novel molecular mechanism of cellular transformation by a mutant molecular chaperone in myeloproliferative neoplasms
por: Araki, Marito, et al.
Publicado: (2017)

Exploration of Small RNAs
por: Kawaji, Hideya, et al.
Publicado: (2008)

Diagnosis- and Prognosis-Related Gene Alterations in BCR::ABL1-Negative Myeloproliferative Neoplasms
por: Morishita, Soji, et al.
Publicado: (2023)

Clinical features of acquired erythrocytosis: Low levels of serum erythropoietin in a subset of non‐neoplastic erythrocytosis patients
por: Mori, Yosuke, et al.
Publicado: (2022)

Restricted Presence of POU6F2 in Human Corneal Endothelial Cells Uncovered by Extension of the Promoter-level Expression Atlas
por: Yoshihara, Masahito, et al.
Publicado: (2017)

Publisher Correction: Nanopore sequencing reveals TACC2 locus complexity and diversity of isoforms transcribed from an intronic promoter
por: Ito, Yosuke, et al.
Publicado: (2021)

Nanopore sequencing reveals TACC2 locus complexity and diversity of isoforms transcribed from an intronic promoter
por: Ito, Yosuke, et al.
Publicado: (2021)

Automated diagnostic support system with deep learning algorithms for distinction of Philadelphia chromosome-negative myeloproliferative neoplasms using peripheral blood specimen
por: Kimura, Konobu, et al.
Publicado: (2021)

Richter's Syndrome with Hypercalcemia Induced by Tumor-Associated Production of Parathyroid Hormone-Related Peptide
por: Watanabe, Naoki, et al.
Publicado: (2017)

SDRF2GRAPH – a visualization tool of a spreadsheet-based description of experimental processes
por: Kawaji, Hideya, et al.
Publicado: (2009)

Correction: Discovery of Molecular Markers to Discriminate Corneal Endothelial Cells in the Human Body
por: Yoshihara, Masahito, et al.
Publicado: (2015)

Discovery of Molecular Markers to Discriminate Corneal Endothelial Cells in the Human Body
por: Yoshihara, Masahito, et al.
Publicado: (2015)

High-resolution promoter map of human limbal epithelial cells cultured with keratinocyte growth factor and rho kinase inhibitor
por: Yoshihara, Masahito, et al.
Publicado: (2017)

Novel biomarkers that assist in accurate discrimination of squamous cell carcinoma from adenocarcinoma of the lung
por: Takamochi, Kazuya, et al.
Publicado: (2016)

Cell-autonomous megakaryopoiesis associated with polyclonal hematopoiesis in triple-negative essential thrombocythemia
por: Inano, Tadaaki, et al.
Publicado: (2021)

Author Correction: Cell-autonomous megakaryopoiesis associated with polyclonal hematopoiesis in triple-negative essential thrombocythemia
por: Inano, Tadaaki, et al.
Publicado: (2022)

Philadelphia-negative chronic myeloproliferative neoplasms
por: Bittencourt, Rosane Isabel, et al.
Publicado: (2012)

The FANTOM5 collection, a data series underpinning mammalian transcriptome atlases in diverse cell types
por: Kawaji, Hideya, et al.
Publicado: (2017)

Correlation of EGFR or KRAS mutation status with (18)F-FDG uptake on PET-CT scan in lung adenocarcinoma
por: Takamochi, Kazuya, et al.
Publicado: (2017)

Molecular biology of Philadelphia-negative myeloproliferative neoplasms
por: Campregher, Paulo Vidal, et al.
Publicado: (2012)

Inflammatory picture of Philadelphia-negative myeloproliferative neoplasms()
por: Pagnano, Katia Borgia Barbosa
Publicado: (2018)

The frequent evolutionary birth and death of functional promoters in mouse and human
por: Young, Robert S., et al.
Publicado: (2015)

Promoter-level transcriptome in primary lesions of endometrial cancer identified biomarkers associated with lymph node metastasis
por: Yoshida, Emiko, et al.
Publicado: (2017)

Effects of Mutational Combinations on Philadelphia-Negative Myeloproliferative Neoplasms
por: Ipek, Yonal-Hindilerden, et al.
Publicado: (2017)

Ocular Manifestations in Patients with Philadelphia-Negative Myeloproliferative Neoplasms
por: Liisborg, Charlotte, et al.
Publicado: (2020)

Philadelphia‐negative myeloproliferative neoplasms among Kuwaiti Nationals
por: Alshemmari, Salem, et al.
Publicado: (2020)

Splenic Infarction in Patients with Philadelphia-negative Myeloproliferative Neoplasms
por: Lee, Myung-Won, et al.
Publicado: (2022)

Applications of Artificial Intelligence in Philadelphia-Negative Myeloproliferative Neoplasms
por: Elsayed, Basel, et al.
Publicado: (2023)

Promoter Usage and Dynamics in Vascular Smooth Muscle Cells Exposed to Fibroblast Growth Factor-2 or Interleukin-1β
por: Alhendi, Ahmad M. N., et al.
Publicado: (2018)

Eprobe mediated RT-qPCR for the detection of leukemia-associated fusion genes
por: Tsuchiya, Koji, et al.
Publicado: (2018)

Conserved temporal ordering of promoter activation implicates common mechanisms governing the immediate early response across cell types and stimuli
por: Vacca, Annalaura, et al.
Publicado: (2018)

Evolving Therapeutic Strategies for the Classic Philadelphia-Negative Myeloproliferative Neoplasms
por: Kaplan, Jason B., et al.
Publicado: (2016)

Philadelphia-negative myeloproliferative neoplasms as disorders marked by cytokine modulation
por: Cacemiro, Maira da Costa, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_9ipt164s4b9r8kk486t3ajvma5